Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Retinal Vein Occlusion: Visual Outcomes and Resolution of Macular Edema.

Miho Inagaki,Yoshio Hirano,Yusuke Yasuda,Mihoko Kawamura,Norihiro Suzuki,Tsutomu Yasukawa,Munenori Yoshida,Yuichiro Ogura

Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Retinal Vein Occlusion: Visual Outcomes and Resolution of Macular Edema.

2021

Miho Inagaki
Yoshio Hirano
Yusuke Yasuda
Mihoko Kawamura
Norihiro Suzuki
Tsutomu Yasukawa
Munenori Yoshida
Yuichiro Ogura

Purpose: To report 24-month results after one intravitreal ranibizumab (IVR) injection followed by pro re nata (PRN) dosing for macular edema (ME) after branch retinal vein occlusion (BRVO). Method...

Keywords:

Medicine
Ranibizumab
intravitreal ranibizumab
Pro re nata
Ophthalmology
Branch retinal vein occlusion
Dosing
Macular edema

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations